Zeyana S. Rivera, Ph.D.

Affiliations: 
2011 University of Hawai'i at Manoa, Honolulu, HI 
Area:
Molecular Biology, Immunology
Google:
"Zeyana Rivera"

Parents

Sign in to add mentor
Michele Carbone grad student 2011 University of Hawai'i at Manoa
 (CSPG4 as a potential target of antibody-based immunotherapy for Malignant Mesothelioma.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Jube SL, Rivera Z, Casalgrandi M, et al. (2013) Abstract 5557: BoxA and ethyl pyruvate offer novel therapeutic approaches for human malignant mesothelioma. Cancer Research. 73: 5557-5557
Croce A, Musa M, Allegrina M, et al. (2013) Micro-Raman spectroscopy identifies crocidolite and erionite fibers in tissue sections Journal of Raman Spectroscopy. 44: 1440-1445
Rivera Z, Ferrone S, Wang X, et al. (2012) CSPG4 as a target of antibody-based immunotherapy for malignant mesothelioma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 5352-63
Jube S, Rivera ZS, Bianchi ME, et al. (2012) Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma. Cancer Research. 72: 3290-301
Jube S, Rivera Z, Bianchi M, et al. (2012) Abstract 1557: High mobility group box 1 secretion supports tumor progression of human malignant mesothelioma Cancer Research. 72: 1557-1557
Testa JR, Cheung M, Pei J, et al. (2011) Germline BAP1 mutations predispose to malignant mesothelioma. Nature Genetics. 43: 1022-5
Carbone M, Baris YI, Bertino P, et al. (2011) Erionite exposure in North Dakota and Turkish villages with mesothelioma. Proceedings of the National Academy of Sciences of the United States of America. 108: 13618-23
Jube S, Rivera Z, Gaudino G, et al. (2011) Abstract 2600: HMGB1, a potential new target for mesothelioma therapy Cancer Research. 71: 2600-2600
Yang H, Rivera Z, Jube S, et al. (2010) Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. Proceedings of the National Academy of Sciences of the United States of America. 107: 12611-6
Yang H, Nasu M, Strianese O, et al. (2009) The legacy of "miracle mineral": asbestos and cancer. Hawaii Medical Journal. 68: 18-20
See more...